Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Clinical Pharmacology and Therapeutics
|
January 21, 2020
A Simulation Approach to Evaluate the Impact of Patterns of Bioanalytical Bias Difference on the Outcome of Pharmacokinetic Similarity Studies
Obinna N Obianom, Olanrewaju O Okusanya, Justin Earp, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
January 27, 2005
Assessment of drug interactions relevant to pharmacodynamic indirect response models
Justin Earp, Wojciech Krzyzanski, Abhijit Chakraborty, et al.
Clinical Pharmacology and Therapeutics
|
November 20, 2023
Creating a Roadmap to Quantitative Systems Pharmacology-Informed Rare Disease Drug Development: A Workshop Report
Jane P F Bai, Audra L Stinchcomb, Jie Wang, et al.
Clinical and Translational Science
|
May 5, 2026
Optimizing Oligonucleotide Therapeutics: A Model-Informed Drug Development Perspective
Ye Yuan, Vishnu Sharma, Venkatesh Atul Bhattaram, et al.
Journal of Pharmaceutical Sciences
|
November 6, 2018
Role of Modeling and Simulation in the Development of Novel and Biosimilar Therapeutic Proteins
Yow-Ming C Wang, Yaning Wang, Sarah J Schrieber, et al.
Journal of Clinical Pharmacology
|
March 1, 2024
Application of Model-Informed Drug Development in Dose Selection and Optimization for siRNA Therapies
Ye Yuan, Liang Li, Justin Earp, et al.
Journal of Clinical Pharmacology
|
September 23, 2022
Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development Program
Kirk Chan-Tack, Mario Sampson, Justin Earp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 6, 2010
U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab
Steven J Lemery, Jenny Zhang, Mark D Rothmann, et al.
Journal of Clinical Pharmacology
|
September 11, 2019
Role of Model-Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling
Youwei Bi, Jiang Liu, Lingjue Li, et al.
Journal of Clinical Pharmacology
|
June 29, 2021
Model-Informed Drug Development in Pediatric Dose Selection
Youwei Bi, Jiang Liu, Fang Li, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Clinical Pharmacology and Therapeutics
|
January 21, 2020
A Simulation Approach to Evaluate the Impact of Patterns of Bioanalytical Bias Difference on the Outcome of Pharmacokinetic Similarity Studies
Obinna N Obianom, Olanrewaju O Okusanya, Justin Earp, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
January 27, 2005
Assessment of drug interactions relevant to pharmacodynamic indirect response models
Justin Earp, Wojciech Krzyzanski, Abhijit Chakraborty, et al.
Clinical Pharmacology and Therapeutics
|
November 20, 2023
Creating a Roadmap to Quantitative Systems Pharmacology-Informed Rare Disease Drug Development: A Workshop Report
Jane P F Bai, Audra L Stinchcomb, Jie Wang, et al.
Clinical and Translational Science
|
May 5, 2026
Optimizing Oligonucleotide Therapeutics: A Model-Informed Drug Development Perspective
Ye Yuan, Vishnu Sharma, Venkatesh Atul Bhattaram, et al.
Journal of Pharmaceutical Sciences
|
November 6, 2018
Role of Modeling and Simulation in the Development of Novel and Biosimilar Therapeutic Proteins
Yow-Ming C Wang, Yaning Wang, Sarah J Schrieber, et al.
Journal of Clinical Pharmacology
|
March 1, 2024
Application of Model-Informed Drug Development in Dose Selection and Optimization for siRNA Therapies
Ye Yuan, Liang Li, Justin Earp, et al.
Journal of Clinical Pharmacology
|
September 23, 2022
Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development Program
Kirk Chan-Tack, Mario Sampson, Justin Earp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 6, 2010
U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab
Steven J Lemery, Jenny Zhang, Mark D Rothmann, et al.
Journal of Clinical Pharmacology
|
September 11, 2019
Role of Model-Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling
Youwei Bi, Jiang Liu, Lingjue Li, et al.
Journal of Clinical Pharmacology
|
June 29, 2021
Model-Informed Drug Development in Pediatric Dose Selection
Youwei Bi, Jiang Liu, Fang Li, et al.
Page
of 2